ACCC greenlights acquisition of Bayer’s animal health business
ACCC 2020-07-09 7:33 pm By Alison Eveleigh | Sydney
Please login to bookmark Close

The Australian Competition and Consumer Commission will not oppose the acquisition of global pharmaceutical giant Bayer’s animal health business by competitor Elanco, after the company agreed to divest certain brands to allay competition concerns.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au